Manufacturer of Controlled Substances; Notice of Application, 34796 [05-11791]

Download as PDF 34796 Federal Register / Vol. 70, No. 114 / Wednesday, June 15, 2005 / Notices If additional information is required contact: Brenda E. Dyer, Clearance Officer, United States Department of Justice, Justice Management Division, Policy and Planning Staff, Patrick Henry Building, Suite 1600, 601 D Street NW., Washington, DC 20530. Dated: June 10, 2005. Brenda E. Dyer, Department Clearance Officer, PRA, Department of Justice. [FR Doc. 05–11777 Filed 6–14–05; 8:45 am] BILLING CODE 4410–AT–P DEPARTMENT OF JUSTICE Antitrust Division Notice Pursuant To The National Cooperative Research and Production Act of 1993—Southwest Research Institute: Joint Industry Project For Fluid Properties Meter Development and Support Notice is hereby given that, on April 11, 2005, pursuant to section 6(a) of the National Cooperative Research Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Southwest Research Institute: Joint Industry Project for Fluid Properties Meter Development and Support (‘‘SwRI: Fluid Properties Meter’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, YZ Systems, Inc., Conroe, TX has been added as a party to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and SwRI: Fluid Properties Meter intends to file additional written notification disclosing all changes in membership. On November 30, 2004, SwRI: Fluid Properties Meter filed its original notification pursuant to section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to section 6(b) of the Act on February 2, 2005 (70 FR 5487), as corrected on May 12, 2005 (70 FR 25111). Dorothy B. Fountain, Deputy Director of Operations Antitrust Division. [FR Doc. 05–11751 Filed 6–14–05; 8:45 am] DEPARTMENT OF JUSTICE DEPARTMENT OF JUSTICE Drug Enforcement Administration Office of Justice Programs Manufacturer of Controlled Substances; Notice of Application Agency Information Collection Activities: Proposed Collection; Comments Requested Pursuant to Section 1301.33(a) of title 21 of the Code of Federal Regulations (CFR), this is notice that on April 27, 2005, Boehringer Ingelheim Chemical Inc., 2820 N. Normandy Drive, Petersburg, Virginia 23805, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in Schedule II: Drug Schedule Amphetamine (1100) .................... Methylphenidate (1724) ................ Methadone (9250) ........................ Methadone Intermediate (9254) ... Dextropropoxyphene, bulk (nondosage form) (9273). Levo-alphacetylmethadol (9648) .. Fentanyl (9801) ............................ 17:57 Jun 14, 2005 Jkt 205001 II II The company plans to manufacture the listed controlled substances for formulation into finished pharmaceuticals. Any other such applicant and any person who is presently registered with DEA to manufacture such a substance may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such written comments or objections being sent via regular mail may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, Washington, DC 20537, Attention: DEA Federal Register Representative, Liaison and Policy Section (ODL); or any being sent via express mail should be sent to DEA Headquarters, Attention: DEA Federal Register Representative/ODL, 2401 Jefferson-Davis Highway, Alexandria, Virginia 22301; and must be filed no later than August 15, 2005. Dated: June 8, 2005. William J. Walker, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 05–11791 Filed 6–14–05; 8:45 am] BILLING CODE 4410–09–P BILLING CODE 4410–11–M VerDate jul<14>2003 II II II II II PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 60-day notice of information collection under review: 2005 Census of State and Federal Correctional Facilities. ACTION: The Department of Justice (DOJ), Office of Justice Programs (OJP), Bureau of Justice Statistics (BJS), has submitted the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection is published to obtain comments from the public and affected agencies. Comments are encouraged and will be accepted for ‘‘sixty days’’ until August 15, 2005. This process is conducted in accordance with 5 CFR 1320.10. If you have comments especially on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact James Stephan, Bureau of Justice Statistics, Office of Justice Programs, Department of Justice, 810 7th Street, NW., Washington, DC 20531, (202) 616–3289. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: —Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; —Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; —Enhance the quality, utility, and clarity of the information to be collected; and —Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Overview of this information collection: E:\FR\FM\15JNN1.SGM 15JNN1

Agencies

[Federal Register Volume 70, Number 114 (Wednesday, June 15, 2005)]
[Notices]
[Page 34796]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-11791]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Section 1301.33(a) of title 21 of the Code of Federal 
Regulations (CFR), this is notice that on April 27, 2005, Boehringer 
Ingelheim Chemical Inc., 2820 N. Normandy Drive, Petersburg, Virginia 
23805, made application by renewal to the Drug Enforcement 
Administration (DEA) to be registered as a bulk manufacturer of the 
basic classes of controlled substances listed in Schedule II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Amphetamine (1100).........................  II
Methylphenidate (1724).....................  II
Methadone (9250)...........................  II
Methadone Intermediate (9254)..............  II
Dextropropoxyphene, bulk (non-dosage form)   II
 (9273).
Levo-alphacetylmethadol (9648).............  II
Fentanyl (9801)............................  II
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
for formulation into finished pharmaceuticals.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such a substance may file comments or 
objections to the issuance of the proposed registration pursuant to 21 
CFR 1301.33(a).
    Any such written comments or objections being sent via regular mail 
may be addressed, in quintuplicate, to the Deputy Assistant 
Administrator, Office of Diversion Control, Drug Enforcement 
Administration, Washington, DC 20537, Attention: DEA Federal Register 
Representative, Liaison and Policy Section (ODL); or any being sent via 
express mail should be sent to DEA Headquarters, Attention: DEA Federal 
Register Representative/ODL, 2401 Jefferson-Davis Highway, Alexandria, 
Virginia 22301; and must be filed no later than August 15, 2005.

    Dated: June 8, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 05-11791 Filed 6-14-05; 8:45 am]
BILLING CODE 4410-09-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.